Abbott Profit Beats Estimates on Growth of Diagnostics

Abbott Laboratories, the largest maker of heart stents and adult nutritional drinks, reported first-quarter profit that beat reduced expectations of analysts, as only diagnostic and eye care products turned in higher sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.